'Breakthrough' mRNA cancer drug curbs melanoma in large trial
Summary
US drug companies Merck and Moderna reported positive results from a large clinical trial of a personalized cancer treatment using mRNA technology. The treatment reduced the return of melanoma tumors, marking a notable success in cancer care research.Key Facts
- The drug uses mRNA technology, similar to some COVID-19 vaccines, to treat cancer.
- The treatment targets melanoma, a serious form of skin cancer.
- This is the first large, late-stage clinical trial to show positive results for an mRNA cancer drug.
- The trial demonstrated that the drug lowers the chance of melanoma tumors coming back after treatment.
- Merck and Moderna, both US-based drugmakers, developed the cancer treatment.
- mRNA treatments work by teaching the body’s cells to fight cancer.
- Experts describe this trial result as a significant breakthrough in cancer therapy development.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
